KQED Nightly Business Report August 25, 2016
Medical association, democratic e on ageing. They are all adding their names to the list of those concerned about the rising price of epipens. The medication that can stop life threatening allergic reactions. As the criticism grows, so does the pressure on mylan. Shares fell 5 today and are down about 12 since friday me relationsh growth of epipen sales. The s the epipen only heightened today with washington ratcheting up the pressure. Pharmaceutical companies that often try to portray themselves as if the inventor medication, often do real damage to by being greed di. And jacking up prices in...